{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:59:30Z","timestamp":1793303970831,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>With the global prevalence of hyperuricemia and gout rising, accumulating evidence has linked acute gout flares to a transient rise in major adverse cardiovascular events, including myocardial infarction and stroke. However, the reverse association, whether acute stroke is associated with an increased incidence of gout flares, has been inadequately investigated. The aim of this single-center cohort study, coupled with a systematic review and meta-analysis, was to evaluate the incidence and characteristics of gout flares in the early post-stroke period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A systematic review and meta-analysis of published studies was conducted, incorporating data from a cohort of acute stroke patients admitted to a tertiary care stroke center. Eligible studies reported in-hospital gout flares among patients with acute ischemic or hemorrhagic stroke. Pooled estimates were calculated using random-effects models. The systematic review was pre-registered in PROSPERO (CRD420251061747).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified three studies (one involving only acute ischemic stroke, two including both ischemic and hemorrhagic stroke), encompassing a total of 13,722 acute stroke patients, including our institutional cohort. The pooled incidence of in-hospital gout flares was 4% (95% CI, 2\u20136%; I\u00b2=88.1%). The pooled mean time to flare onset was 6.3 days post-stroke (95% CI, 4.09\u20138.44; I\u00b2=96.6%), and 64% of flares involved the paretic limb (95% CI, 33\u201390%; I\u00b2=62.1%). Among flare patients, 85% were male (95% CI, 40\u2013100%; I\u00b2=84.5%), 97% had ischemic stroke (95% CI, 94\u201399%; I\u00b2=0%), and 61% were newly diagnosed with gout or hyperuricemia during hospitalization (95% CI, 48\u201373%; I\u00b2=0%). In our cohort, 50% and 12.5% of flare patients presented with delirium and aphasia, respectively; all patients received colchicine treatment with complete symptom resolution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Gout flares occur in one out of every 25 acute stroke patients, particularly in men presenting with acute ischemic stroke within the first week after symptom onset, and frequently involve the paretic limb. In over half of cases, the flare uncovers previously undiagnosed gout or hyperuricemia, emphasizing the need for systematic evaluation, particularly in patients with delirium or impaired communication, where diagnosis may be delayed. Early colchicine initiation warrants consideration given its anti-inflammatory effects and potential to reduce stroke recurrence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s42466-025-00424-w","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:35:59Z","timestamp":1760542559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gout flares following acute stroke: a single-center cohort and a systematic review\/meta-analysis"],"prefix":"10.1186","volume":"7","author":[{"given":"Evangelos","family":"Panagiotopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Kotsali-Peteinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Papagiannopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Theodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chondrogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Bakola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Palaiodimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klearchos","family":"Psychogios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odysseas","family":"Kargiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Safouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota-Eleni","family":"Tsalouchidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annerose","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Krogias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2305-6627","authenticated-orcid":false,"given":"Maria-Ioanna","family":"Stefanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"424_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fmed.2020.00560","volume":"7","author":"I Calabuig","year":"2020","unstructured":"Calabuig, I., G\u00f3mez-Garber\u00ed, M., & Andr\u00e9s, M. (2020). Gout is prevalent but under-registered among patients with cardiovascular events: A field study. Frontiers in Medicine, 7, 560. https:\/\/doi.org\/10.3389\/fmed.2020.00560","journal-title":"Frontiers in Medicine"},{"issue":"10287","key":"424_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth, N., Gosling, A. L., Gaffo, A., & Abhishek, A. (2021). Gout. The Lancet, 397(10287), 1843\u20131855. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9","journal-title":"The Lancet"},{"issue":"4","key":"424_CR3","doi-asserted-by":"publisher","first-page":"101716","DOI":"10.1016\/j.berh.2021.101716","volume":"35","author":"S Stewart","year":"2021","unstructured":"Stewart, S., Dalbeth, N., & Gaffo, A. (2021). The challenge of gout flare measurement. Best Practice & Research Clinical Rheumatology, 35(4), 101716. https:\/\/doi.org\/10.1016\/j.berh.2021.101716","journal-title":"Best Practice & Research Clinical Rheumatology"},{"issue":"5","key":"424_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/jama.2022.11390","volume":"328","author":"E Cipolletta","year":"2022","unstructured":"Cipolletta, E., Tata, L. J., Nakafero, G., Avery, A. J., Mamas, M. A., & Abhishek, A. (2022). Association between gout flare and subsequent cardiovascular events among patients with gout. Journal of the American Medical Association, 328(5), 440\u2013450. https:\/\/doi.org\/10.1001\/jama.2022.11390","journal-title":"Journal of the American Medical Association"},{"issue":"12","key":"424_CR5","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/rheumatology\/ket293","volume":"52","author":"OO Seminog","year":"2013","unstructured":"Seminog, O. O., & Goldacre, M. J. (2013). Gout as a risk factor for myocardial infarction and stroke in england: Evidence from record linkage studies. Rheumatology, 52(12), 2251\u20132259. https:\/\/doi.org\/10.1093\/rheumatology\/ket293","journal-title":"Rheumatology"},{"issue":"13","key":"424_CR6","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.3390\/jcm11133779","volume":"11","author":"PH Tsai","year":"2022","unstructured":"Tsai, P. H., Kuo, C. F., See, L. C., Li, P. R., Chen, J. S., & Tseng, W. Y. (2022). Stroke risk in patients with gout: A nationwide retrospective cohort study in Taiwan. Journal of Clinical Medicine, 11(13), 3779. https:\/\/doi.org\/10.3390\/jcm11133779","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"424_CR7","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","volume":"3","author":"R Hansildaar","year":"2021","unstructured":"Hansildaar, R., Vedder, D., Baniaamam, M., Tausche, A. K., Gerritsen, M., & Nurmohamed, M. T. (2021). Cardiovascular risk in inflammatory arthritis: Rheumatoid arthritis and gout. The Lancet Rheumatology, 3(1), e58\u2013e70. https:\/\/doi.org\/10.1016\/S2665-9913(20)30221-6","journal-title":"The Lancet Rheumatology"},{"issue":"8","key":"424_CR8","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1161\/STROKEAHA.121.034388","volume":"52","author":"PJ Kelly","year":"2021","unstructured":"Kelly, P. J., Lemmens, R., & Tsivgoulis, G. (2021). Inflammation and stroke risk: A new target for prevention. Stroke, 52(8), 2697\u20132706. https:\/\/doi.org\/10.1161\/STROKEAHA.121.034388","journal-title":"Stroke"},{"issue":"2","key":"424_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/STROKEAHA.122.037155","volume":"54","author":"SN Ohashi","year":"2023","unstructured":"Ohashi, S. N., DeLong, J. H., Kozberg, M. G., Mazur-Hart, D. J., van Veluw, S. J., Alkayed, N. J., et al. (2023). Role of inflammatory processes in hemorrhagic stroke. Stroke, 54(2), 605\u2013619. https:\/\/doi.org\/10.1161\/STROKEAHA.122.037155","journal-title":"Stroke"},{"issue":"9","key":"424_CR10","doi-asserted-by":"publisher","first-page":"e16269","DOI":"10.15252\/emmm.202216269","volume":"14","author":"A Simats","year":"2022","unstructured":"Simats, A., & Liesz, A. (2022). Systemic inflammation after stroke: Implications for post-stroke comorbidities. EMBO Molecular Medicine, 14(9), e16269. https:\/\/doi.org\/10.15252\/emmm.202216269","journal-title":"EMBO Molecular Medicine"},{"issue":"2","key":"424_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5455\/medarh.2020.74.95-99","volume":"74","author":"N Serdarevic","year":"2020","unstructured":"Serdarevic, N., Stanciu, A. E., Begic, L., & Uncanin, S. (2020). Serum uric acid concentration in patients with cerebrovascular disease (ischemic stroke and vascular dementia). Medical Archives, 74(2), 95\u201399. https:\/\/doi.org\/10.5455\/medarh.2020.74.95-99","journal-title":"Medical Archives"},{"key":"424_CR12","doi-asserted-by":"publisher","first-page":"102835","DOI":"10.1016\/j.eclinm.2024.102835","volume":"76","author":"ATL Fiolet","year":"2024","unstructured":"Fiolet, A. T. L., Poorthuis, M. H. F., Opstal, T. S. J., Amarenco, P., Boczar, K. E., Buysschaert, I., et al. (2024). Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: A meta-analysis of randomised trials. eClinicalMedicine, 76, 102835. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102835","journal-title":"eClinicalMedicine"},{"issue":"10","key":"424_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/13543784.2021.1985463","volume":"30","author":"A Safouris","year":"2021","unstructured":"Safouris, A., Magoufis, G., & Tsivgoulis, G. (2021). Emerging agents for the treatment and prevention of stroke: Progress in clinical trials. Expert Opinion on Investigational Drugs, 30(10), 1025\u20131035. https:\/\/doi.org\/10.1080\/13543784.2021.1985463","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"6","key":"424_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2174\/1381612824666180116100310","volume":"24","author":"G Tsivgoulis","year":"2018","unstructured":"Tsivgoulis, G., Katsanos, A. H., Giannopoulos, G., Panagopoulou, V., Jatuzis, D., Lemmens, R., et al. (2018). The role of Colchicine in the prevention of cerebrovascular ischemia. Current Pharmaceutical Design, 24(6), 668\u2013674. https:\/\/doi.org\/10.2174\/1381612824666180116100310","journal-title":"Current Pharmaceutical Design"},{"issue":"5","key":"424_CR15","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3390\/jcm12051937","volume":"12","author":"V Siokas","year":"2023","unstructured":"Siokas, V., Roesch, S., Stefanou, M. I., Buesink, R., Wilke, V., Sartor-Pfeiffer, J., et al. (2023). Effects of melatonin administration on post-stroke delirium in patients with intracerebral hemorrhage. Journal of Clinical Medicine, 12(5), 1937. https:\/\/doi.org\/10.3390\/jcm12051937","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"424_CR16","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1111\/ene.14792","volume":"28","author":"A Mengel","year":"2021","unstructured":"Mengel, A., Zurloh, J., Bo\u00dfelmann, C., Brendel, B., Stadler, V., Sartor-Pfeiffer, J., et al. (2021). Delirium reduction after administration of melatonin in acute ischemic stroke (dreams): A propensity score-matched analysis. European Journal of Neurology, 28(6), 1958\u20131966. https:\/\/doi.org\/10.1111\/ene.14792","journal-title":"European Journal of Neurology"},{"key":"424_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3389\/fneur.2019.01198","volume":"10","author":"C Bo\u00dfelmann","year":"2019","unstructured":"Bo\u00dfelmann, C., Zurloh, J., Stefanou, M. I., Stadler, V., Weber, Y., Lerche, H., et al. (2019). Delirium screening in aphasic patients with the intensive care delirium screening checklist (icdsc): A prospective cohort study. Frontiers in Neurology, 10, 1198. https:\/\/doi.org\/10.3389\/fneur.2019.01198","journal-title":"Frontiers in Neurology"},{"issue":"19","key":"424_CR18","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.3390\/jcm11195835","volume":"11","author":"V Siokas","year":"2022","unstructured":"Siokas, V., Fleischmann, R., Feil, K., Liampas, I., Kowarik, M. C., Bai, Y., et al. (2022). The role of vascular risk factors in post-stroke delirium: A systematic review and meta-analysis. Journal of Clinical Medicine, 11(19), 5835. https:\/\/doi.org\/10.3390\/jcm11195835","journal-title":"Journal of Clinical Medicine"},{"issue":"5","key":"424_CR19","doi-asserted-by":"publisher","first-page":"104764","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104764","volume":"29","author":"C Wu","year":"2020","unstructured":"Wu, C., Qin, Y., Lin, Z., Yi, X., Wei, X., Ruan, Y., et al. (2020). Prevalence and impact of aphasia among patients admitted with acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association, 29(5), 104764. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104764","journal-title":"Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association"},{"issue":"5","key":"424_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00134-024-07388-6","volume":"50","author":"NE Brummel","year":"2024","unstructured":"Brummel, N. E., Hughes, C. G., McNeil, J. B., Pandharipande, P. P., Thompson, J. L., Orun, O. M., et al. (2024). Systemic inflammation and delirium during critical illness. Intensive Care Medicine, 50(5), 687\u2013696. https:\/\/doi.org\/10.1007\/s00134-024-07388-6","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"424_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5371\/hp.2024.36.1.1","volume":"36","author":"Y Cha","year":"2024","unstructured":"Cha, Y., Lee, J., Choy, W., Lee, J. S., Lee, H. H., & Chae, D. S. (2024). Pathophysiology and treatment of gout arthritis; including gout arthritis of hip joint: A literature review. Hip & Pelvis, 36(1), 1\u201311. https:\/\/doi.org\/10.5371\/hp.2024.36.1.1","journal-title":"Hip & Pelvis"},{"issue":"1","key":"424_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.46497\/ArchRheumatol.2025.10808","volume":"40","author":"H Jiang","year":"2025","unstructured":"Jiang, H., Su, Y., Liu, R., Xu, X., Xu, Q., Yang, J., et al. (2025). Hyperuricemia and the risk of stroke incidence and mortality: A systematic review and meta-analysis. Archives of Rheumatology, 40(1), 128\u2013143. https:\/\/doi.org\/10.46497\/ArchRheumatol.2025.10808","journal-title":"Archives of Rheumatology"},{"issue":"9596","key":"424_CR23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., G\u00f8tzsche, P. C., Vandenbroucke, J. P., et al. (2007). The strengthening the reporting of observational studies in epidemiology (strobe) statement: Guidelines for reporting observational studies. Lancet (London England), 370(9596), 1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet (London England)"},{"issue":"10","key":"424_CR24","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi, T., Jansen, T. L. T. A., Dalbeth, N., Fransen, J., Schumacher, H. R., Berendsen, D., et al. (2015). 2015 gout classification criteria: An American college of rheumatology\/european league against rheumatism collaborative initiative. Annals of the Rheumatic Diseases, 74(10), 1789\u20131798. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208237","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"424_CR25","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg, S. M., Ziai, W. C., Cordonnier, C., Dowlatshahi, D., Francis, B., Goldstein, J. N., et al. (2022). 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American heart association\/american stroke association. Stroke, 53(7), e282\u2013e361. https:\/\/doi.org\/10.1161\/STR.0000000000000407","journal-title":"Stroke"},{"issue":"12","key":"424_CR26","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., et al. (2019). Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American heart association\/american stroke association. Stroke, 50(12), e344\u2013e418. https:\/\/doi.org\/10.1161\/STR.0000000000000211","journal-title":"Stroke"},{"issue":"10","key":"424_CR27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., G\u00f8tzsche, P. C., Ioannidis, J. P. A., et al. (2009). The Prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Journal of Clinical Epidemiology, 62(10), e1\u2013e34. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.006","journal-title":"Journal of Clinical Epidemiology"},{"key":"424_CR28","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne, J. A., Hern\u00e1n, M. A., Reeves, B. C., Savovi\u0107, J., Berkman, N. D., Viswanathan, M., et al. (2016). ROBINS-i: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical Research ed), 355, i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ (Clinical Research ed)"},{"issue":"7568","key":"424_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","volume":"333","author":"J Lau","year":"2006","unstructured":"Lau, J., Ioannidis, J. P. A., Terrin, N., Schmid, C. H., & Olkin, I. (2006). The case of the misleading funnel plot. BMJ (Clinical Research ed), 333(7568), 597\u2013600. https:\/\/doi.org\/10.1136\/bmj.333.7568.597","journal-title":"BMJ (Clinical Research ed)"},{"issue":"3","key":"424_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"424_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina, T. B., S\u00e1nchez-Meca, J., Mar\u00edn-Mart\u00ednez, F., & Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or i2 index? Psychological Methods, 11(2), 193\u2013206. https:\/\/doi.org\/10.1037\/1082-989X.11.2.193","journal-title":"Psychological Methods"},{"issue":"12","key":"424_CR32","first-page":"819","volume":"86","author":"K Chakravarty","year":"1993","unstructured":"Chakravarty, K., Durkin, C. J., Hillawi, A. H., al-, Bodley, R., & Webley, M. (1993). The incidence of acute arthritis in stroke patients, and its impact on rehabilitation. The Quarterly Journal of Medicine, 86(12), 819\u2013823.","journal-title":"The Quarterly Journal of Medicine"},{"issue":"4","key":"424_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000235626","volume":"28","author":"YH Lin","year":"2009","unstructured":"Lin, Y. H., Hsu, H. L., Huang, Y. C., Lee, M., Huang, W. Y., Huang, Y. C., et al. (2009). Gouty arthritis in acute cerebrovascular disease. Cerebrovascular Diseases, 28(4), 391\u2013396. https:\/\/doi.org\/10.1159\/000235626","journal-title":"Cerebrovascular Diseases"},{"key":"424_CR34","doi-asserted-by":"publisher","first-page":"108326","DOI":"10.1016\/j.clineuro.2024.108326","volume":"242","author":"S Tan","year":"2024","unstructured":"Tan, S., Liu, Y., Li, F., Han, M., & Ye, M. (2024). The impact of various antiplatelet strategies on the incidence of gouty arthritis in hospitalized patients with acute cerebral infarction. Clinical Neurology and Neurosurgery, 242, 108326. https:\/\/doi.org\/10.1016\/j.clineuro.2024.108326","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"6","key":"424_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/acr2.11540","volume":"5","author":"D Lopez","year":"2023","unstructured":"Lopez, D., Dwivedi, G., Nossent, J., Preen, D. B., Murray, K., Raymond, W., et al. (2023). Risk of major adverse cardiovascular event following incident hospitalization for acute gout: A Western Australian population-level linked data study. ACR Open Rheumatology, 5(6), 298\u2013304. https:\/\/doi.org\/10.1002\/acr2.11540","journal-title":"ACR Open Rheumatology"},{"issue":"6","key":"424_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/RHU.0b013e3181eed855","volume":"16","author":"SJ Hsiao","year":"2010","unstructured":"Hsiao, S. J., Vaynrub, M., Furer, V., & Samuels, J. (2010). Polyarticular gout attacks following cerebrovascular accidents: Is hemiparesis in fact protective? 2 cases and a review of the literature. JCR: Journal of Clinical Rheumatology, 16(6), 293. https:\/\/doi.org\/10.1097\/RHU.0b013e3181eed855","journal-title":"JCR: Journal of Clinical Rheumatology"},{"key":"424_CR37","doi-asserted-by":"publisher","unstructured":"Hayashi, H., Kato, A., Tomiyama, N., & Ogihara, H. (2025). Hand edema and venous return after stroke: A preliminary study. Neurorehabilitation, 10538135251336060. https:\/\/doi.org\/10.1177\/10538135251336060","DOI":"10.1177\/10538135251336060"},{"issue":"4","key":"424_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000080353","volume":"18","author":"FM Ivey","year":"2004","unstructured":"Ivey, F. M., Gardner, A. W., Dobrovolny, C. L., & Macko, R. F. (2004). Unilateral impairment of leg blood flow in chronic stroke patients. Cerebrovascular Diseases (Basel Switzerland), 18(4), 283\u2013289. https:\/\/doi.org\/10.1159\/000080353","journal-title":"Cerebrovascular Diseases (Basel Switzerland)"},{"issue":"22","key":"424_CR39","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/09638280310001603992","volume":"25","author":"MWM Post","year":"2003","unstructured":"Post, M. W. M., Visser-Meily, J. M. A., Boomkamp-Koppen, H. G. M., & Prevo, A. J. H. (2003). Assessment of oedema in stroke patients: Comparison of visual inspection by therapists and volumetric assessment. Disability and Rehabilitation, 25(22), 1265\u20131270. https:\/\/doi.org\/10.1080\/09638280310001603992","journal-title":"Disability and Rehabilitation"},{"issue":"1","key":"424_CR40","doi-asserted-by":"publisher","first-page":"8531","DOI":"10.1038\/s41598-021-88050-9","volume":"11","author":"SJ Wang","year":"2021","unstructured":"Wang, S. J., Lee, C. H., Kang, H. G., Kim, K. W., Kim, M., Jeong, H. J., et al. (2021). Peripheral vasoreactivity in acute ischemic stroke with hemiplegia. Scientific Reports, 11(1), 8531. https:\/\/doi.org\/10.1038\/s41598-021-88050-9","journal-title":"Scientific Reports"},{"issue":"6","key":"424_CR41","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello-Petersen, R., Guyatt, G., Abeles, A. M., et al. (2020). 2020 American college of rheumatology guideline for the management of gout. Arthritis Care & Research, 72(6), 744\u2013760. https:\/\/doi.org\/10.1002\/acr.24180","journal-title":"Arthritis Care & Research"},{"issue":"2","key":"424_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/jnnp-2016-314817","volume":"89","author":"PJ Kelly","year":"2018","unstructured":"Kelly, P. J., Murphy, S., Coveney, S., Purroy, F., Lemmens, R., Tsivgoulis, G., et al. (2018). Anti-inflammatory approaches to ischaemic stroke prevention. Journal of Neurology Neurosurgery and Psychiatry, 89(2), 211\u2013218. https:\/\/doi.org\/10.1136\/jnnp-2016-314817","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"2","key":"424_CR43","doi-asserted-by":"publisher","first-page":"108167","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108167","volume":"34","author":"G Noll","year":"2025","unstructured":"Noll, G., Borelli, W. V., Mantovani, G. P., Martins, S. C. O., & Sposato, L. A. (2025). Low-dose Colchicine for stroke prevention: A systematic overview of systematic reviews and meta-analyses. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association, 34(2), 108167. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.108167","journal-title":"Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association"},{"key":"424_CR44","doi-asserted-by":"publisher","first-page":"e079061","DOI":"10.1136\/bmj-2023-079061","volume":"385","author":"J Li","year":"2024","unstructured":"Li, J., Meng, X., Shi, F. D., Jing, J., Gu, H. Q., Jin, A., et al. (2024). Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (chance-3): Multicentre, double blind, randomised, placebo controlled trial. BMJ (Clinical Research ed), 385, e079061. https:\/\/doi.org\/10.1136\/bmj-2023-079061","journal-title":"BMJ (Clinical Research ed)"},{"issue":"8","key":"424_CR45","doi-asserted-by":"publisher","first-page":"CD006190","DOI":"10.1002\/14651858.CD006190.pub3","volume":"2021","author":"BJ McKenzie","year":"2021","unstructured":"McKenzie, B. J., Wechalekar, M. D., Johnston, R. V., Schlesinger, N., & Buchbinder, R. (2021). Colchicine for acute gout. The Cochrane Database of Systematic Reviews, 2021(8), CD006190. https:\/\/doi.org\/10.1002\/14651858.CD006190.pub3","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"424_CR46","doi-asserted-by":"publisher","first-page":"925211","DOI":"10.3389\/fcvm.2022.925211","volume":"9","author":"JJ Yeh","year":"2022","unstructured":"Yeh, J. J., Hung, T. W., Lin, C. L., Chen, T. T., Liw, P. X., Yu, Y. L., et al. (2022). Colchicine is a weapon for managing the heart disease among interstitial lung disease with viral infection: Have we found the holy grail? Frontiers in Cardiovascular Medicine, 9, 925211. https:\/\/doi.org\/10.3389\/fcvm.2022.925211","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"3","key":"424_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12028-020-00959-7","volume":"32","author":"AM Cook","year":"2020","unstructured":"Cook, A. M., Morgan Jones, G., Hawryluk, G. W. J., Mailloux, P., McLaughlin, D., Papangelou, A., et al. (2020). Guidelines for the acute treatment of cerebral edema in neurocritical care patients. Neurocritical Care, 32(3), 647\u2013666. https:\/\/doi.org\/10.1007\/s12028-020-00959-7","journal-title":"Neurocritical Care"},{"issue":"3","key":"424_CR48","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/STROKEAHA.115.012231","volume":"47","author":"J Sundb\u00f8ll","year":"2016","unstructured":"Sundb\u00f8ll, J., Horv\u00e1th-Puh\u00f3, E., Schmidt, M., Dekkers, O. M., Christiansen, C. F., Pedersen, L., et al. (2016). Preadmission use of glucocorticoids and 30-day mortality after stroke. Stroke, 47(3), 829\u2013835. https:\/\/doi.org\/10.1161\/STROKEAHA.115.012231","journal-title":"Stroke"},{"key":"424_CR49","doi-asserted-by":"publisher","first-page":"c7086","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S Trelle","year":"2011","unstructured":"Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., et al. (2011). Cardiovascular safety of non-steroidal anti-inflammatory drugs: Network meta-analysis. The BMJ, 342, c7086. https:\/\/doi.org\/10.1136\/bmj.c7086","journal-title":"The BMJ"},{"issue":"12","key":"424_CR50","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996). A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology, 49(12), 1373\u20131379. https:\/\/doi.org\/10.1016\/s0895-4356(96)00236-3","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-025-00424-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-025-00424-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-025-00424-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:36:00Z","timestamp":1760542560000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-025-00424-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1186\/s42466-025-00424-w","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The single-center cohort study was approved by the Ethics Committee of Attikon University Hospital (decision number: EBD 444\/13-06-2024). All patients or their legally authorized representatives provided informed consent for participation. The systematic review and meta-analysis used only previously published data and did not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}